Cargando…
The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in De Novo Pediatric Acute Leukemias
BACKGROUND: JL1 is a newly identified CD43 epitope that specifically recognizes leukemic cells. We analyzed the incidence of JL1 expression and compared the clinical, immunophenotypic, and genetic characteristics of de novo pediatric acute leukemia patients with respect to JL1 expression status to d...
Autores principales: | Park, Sang Hyuk, You, Eunkyoung, Park, Chan-Jeoung, Jang, Seongsoo, Cho, Young-Uk, Yoon, Chan Hee, Koh, Kyung-Nam, Im, Ho-Joon, Seo, Jong-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400720/ https://www.ncbi.nlm.nih.gov/pubmed/30809981 http://dx.doi.org/10.3343/alm.2019.39.4.358 |
Ejemplares similares
-
JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma
por: Kim, Min-Sun, et al.
Publicado: (2020) -
Immunotherapeutic potential of JL1, a thymocyte surface protein, for leukemia.
por: Kim, T. J., et al.
Publicado: (1998) -
Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2
por: Chambers, Phil, et al.
Publicado: (2009) -
Thermus oshimai JL-2 and T. thermophilus JL-18 genome analysis illuminates pathways for carbon, nitrogen, and sulfur cycling
por: Murugapiran, Senthil K., et al.
Publicado: (2013) -
Polymake.jl: A New Interface to polymake
por: Kaluba, Marek, et al.
Publicado: (2020)